The success of Sildenafil initially sparked a surge for pharma, however recent developments present a uncertain picture for those considering a stake. Lower-cost competitors are eating into profits, and persistent https://delilahxwtj828665.theisblog.com/41605856/the-blue-pill-and-big-pharma-a-risky-play